PLX Overview
Upcoming Projects (PLX)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (PLX)
-
Potential for Protalix' (PLX) OPRX-106 in Ulcerative Colitis, and What to Expect from Phase 2 Data
Ticker: PLX
Execute By: Mar 31, 2017
Upcoming & Overdue Catalysts (PLX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (PLX)
-
Preliminary Data Posted from Protalix's (PLX) BRIDGE Study of pegunigalsidase alfa (PRX-102) for the Treatment of Fabry Disease
Ticker: PLX
Occurred on: Sep 21, 2018 -
Phase 2 Data due in Q1 2018 for Protalix' (PLX) OPRX-106 in Ulcerative Colitis
Ticker: PLX
Occurred on: Jan 02, 2018 -
Protalix (PLX) Announces Preclinical Results Evaluating PRX-102 in Mouse Models with Fabry Disease
Ticker: PLX
Occurred on: Apr 18, 2017 -
Data from PRX-110 Phase 2 study in Cystic Fibrosis expected by end of 2016
Ticker: PLX
Occurred on: Jan 03, 2017 -
Enrollment Expected to Commence Soon in Phase 2 Trial Evaluating Protalix' (PLX) OPRX-106 in Ulcerative Colitis
Ticker: PLX
Occurred on: Nov 30, 2016 -
Protalix BioTherapeutics Announces First Patient Dosed in the AIR DNase Phase II Clinical Trial for Cystic Fibrosis
Ticker: PLX
Occurred on: Jul 07, 2016
Strategic Initiatives (PLX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
